Proximity of Immune and Tumor Cells and Response to Targeted Therapies in Metastatic Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients
NPJ Precis Oncol 2022 Jan 20;6(1)6, C Yan, SC Chen, GD Ayers, CA Nebhan, JT Roland, VL Weiss, DB Johnson, A RichmondFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.